PROK · NASDAQ · Biotechnology

ProKidney

Develops rilparencel for advanced chronic kidney disease and type 2 diabetes.

$1.80
After-hours close−0.03 (−1.91%)
At close$1.84(+0.82%)

Breakdown13F · Form 4

Institutions 28.79%Insiders 72.52%

Institutions and insiders are filed separately and overlap, so together they can pass the whole company. No split is drawn from them.

Shares outstanding 148.17M · Float

Float — provider float is below the insider stake.

The provider's float is smaller than the insider stake it should exclude, so it is not shown.

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Control Empresarial de Capitales S.A. de C.V. · 10 percent owner, other: Add'l Rep. Persons-see Ex.99-1147.69M99.68%Form 4Apr 30, 2026
Tolerantia, LLC106.90M36.50%13DJun 5, 2025
Pablo G. Legorreta · director, 10 percent owner: 106.90M72.15%Form 4Jun 5, 2025
Suvretta Capital Management, LLC12.34M8.33%13FMay 15, 2026
Morgan Stanley8.96M6.04%13FMay 15, 2026

Institutions13F, as of Mar 31, 2026

72 holders · 42.66M shares · 17 new positions · 38 increased · 20 reduced · 9 closed

HolderShares% outstandingChg q/qFiled
Suvretta Capital Management, LLC12.34M8.33%0May 15, 2026
Morgan Stanley8.96M6.04%+139.0KMay 15, 2026
Millennium Management LLC2.27M1.53%+437.0KMay 15, 2026
Bleichroeder LP2.00M1.35%0May 14, 2026
Artia Global Partners LP1.81M1.22%−31.5KMay 15, 2026
Hennion & Walsh Asset Management, Inc.1.61M1.09%+107.8KMay 13, 2026
BlackRock, Inc.1.39M0.94%−17.1KMay 13, 2026
Renaissance Technologies LLC1.25M0.84%+355.1KMay 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Tolerantia, LLC36.50%106.90M13DJun 5, 2025
Control Empresarial de Capitales S.A. de C.V.incl. Carlos Slim Helu, Johanna Monique Slim Domit +5 more36.00%73.84M13DApr 30, 2026
Morgan Stanley6.00%8.52M13GFeb 12, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Control Empresarial de Capitales S.A. de C.V.10 percent owner, other: Add'l Rep. Persons-see Ex.99-1147.69M99.68%Apr 30, 2026
Pablo G. Legorretadirector, 10 percent owner: 106.90M72.15%Jun 5, 2025
Todd C. Girolamoofficer: Chief Legal Officer327.7K0.22%Jun 15, 2026
Brian JG Pereiradirector222.9K0.15%Aug 20, 2026

4 ten-percent owners hold 236.22M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 11 people have not refiled in the last 18 months (13.58M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 20, 2026
Brian JG Pereiradirector
Sale27,052$1.420
Aug 19, 2026
Brian JG Pereiradirector
Sale · 2 lots250,000$1.44250,000
Aug 18, 2026
Brian JG Pereiradirector
Sale · 2 lots257,164$1.37500,000
Nov 13, 2025
Brian JG Pereiradirector
Sale54,333$2.370
Nov 12, 2025
Brian JG Pereiradirector
Sale · 2 lots255,026$2.7254,333

CongressHouse and Senate disclosures

Not reported.